Cannabidiol and fluorinated derivative anti-cancer properties against glioblastoma multiforme cell lines, and synergy with imidazotetrazine agents
This work demonstrates the anti-cancer activity of 4'-F-CBD and the synergy of cannabinoids with imidazotetrazine agents for the first time and expands understanding of CBD mechanism of action.
Authors
- Morgan R. Alexander (ORCID: https://orcid.org/0000-0001-5182-493X)
- Tracey D. Bradshaw (ORCID: https://orcid.org/0000-0001-8451-5092)
- Pavel Gershkovich (ORCID: https://orcid.org/0000-0003-3136-0933)
- David J. Scurr (ORCID: https://orcid.org/0000-0003-0859-3886)
- Nicholas D. Kindon (ORCID: https://orcid.org/0009-0002-2862-052X)
- Alice Brookes (ORCID: https://orcid.org/0000-0003-0804-2275)
Institutions
- University of Nottingham (GB)
Publication Details
- Journal
- BJC Reports
- Published
- 2024-09-09
- DOI
- https://doi.org/10.1038/s44276-024-00088-0
- Citations
- 3
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 1.34
Funders
- Engineering and Physical Sciences Research Council
- EPSRC Centre for Doctoral Training in Medical Imaging